-

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into MGP Ingredients, Inc. (NYSE: MGPI)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether MGP Ingredients, Inc. (“MGP” or the “Company”) (NYSE: MGPI) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws.

CLICK HERE TO LEARN MORE

MGP is a producer and supplier of distilled spirits, branded spirits, and food ingredients. On October 17, 2024, after the market closed, MGP issued a press release negatively announcing preliminary results for 3Q24. The press release revealed, among other things, that the Company expected sales from its Distilling Solutions segment to decline 36%. On this news, the price of the Company’s stock fell more than 24%, or $19.71, to close at $61.86 on October 18, 2024, on heavy trading volume.

Then, on October 31, 2024, during market hours, the Company released its 3Q24 financial results. During the associated earnings call, the Company confirmed the previously announced 36% decline in Distilling Solutions sales. On this news, the price of the Company’s stock fell an additional $8.27, or nearly 15%, to close at $48.04 on October 31, 2024, on heavy trading volume.

What You Can Do – CLICK HERE FOR YOUR OPTIONS AS A SHAREHOLDER

If you purchased or otherwise own MGP securities and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Nicholas Bruno at (888) 398-9312 or at nbruno@scott-scott.com.

About Scott+Scott

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, Virginia, and Ohio.

This may be considered Attorney Advertising.

Contacts

Nicholas Bruno
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 24th Floor, New York, NY 10169
(888) 398-9312
nbruno@scott-scott.com

Scott+Scott Attorneys at Law LLP

NYSE:MGPI

Release Versions

Contacts

Nicholas Bruno
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 24th Floor, New York, NY 10169
(888) 398-9312
nbruno@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Cardinal Infrastructure Group Inc. (NASDAQ: CDNL)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, alerts investors that it is investigating potential violations of U.S. federal securities laws involving Cardinal Infrastructure Group Inc. (NASDAQ: CDNL).CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTIONWhat is Cardinal Infrastructure?Cardinal Infrastructure is a North Carolina-based infrastructure construction company specializing in under...

SIX FLAGS ENTERTAINMENT CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Six Flags Entertainment Corporation’s Directors and Officers for Breach of Fiduciary Duties – FUN

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Six Flags Entertainment Corporation (NYSE: FUN) failed to manage Six Flags in an acceptable manner, breaching their fiduciary duties to Six Flags, and whether Six Flags and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On October 12, 2026, a man died after bein...

BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT:  Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation’s Directors and Officers for Breach of Fiduciary Duties – BSX

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Boston Scientific in an acceptable manner, breaching their fiduciary duties to Boston Scientific, and whether Boston Scientific and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On February 4, 2026, B...
Back to Newsroom